Estée Lauder
Up to $5,000
Claims opening soon
Allergan agreed to pay nearly $30 million to resolve claims it used anti-competitive tactics to raise Restasis prices.
Alleged antitrust violations involving price increases for Restasis eye drops.
This settlement resolves claims that Allergan used anti-competitive tactics to raise prices on Restasis eye drops. Eligible consumers and third-party payors who purchased Restasis in specified states between May 2015 and July 2021 may receive compensation.
Varies
Claim status: Closed on August 11, 2022
Estée Lauder
Up to $5,000
Claims opening soon
Silk and Great Value
Up to $300,000
96 days left
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
746 days left

Meta (Facebook)
Up to $90
Claims opening soon
Ticketmaster
Compensation pending
Claims opening soon